Mandate

Vinge advised Dagon in relation to expansion of its property portfolio in Gothenburg

November 02, 2010

Dagon has acquired the industrial property designated as Sävenäs 170:13 in Gothenburg from L-Å Eveberg Fastighetsutveckling AB. The property is situated adjacent to Dagon’s property designated as Sävenäs 170:14 on von Utfallsgatan in Gothenburg. The purchase price was based on a total underlying property value of SEK 16. 9 million. Completion was scheduled to occur on 1 November 2010. The acquisition was effected through a share transfer of the real estate holding company.

Dagon also acquired two properties designated as Tuve 86:2 and Tynnered 1: 15 in Gothenburg. The properties are currently fully let and annual rental income amounts to approximately SEK 6.4 million. The purchase price was based on a total underlying property value of SEK 72.5 million. Completion was scheduled to occur on 1 November 2010.

Dagon AB (publ) is a property development company with an estate portfolio with a market value of approximately SEK 5 billion. The portfolio primarily consists of commercial properties and some project development properties in southern and central Sweden. Dagon AB is listed on NASDAQ OMX Stockholm.

Vinge’s team consisted of Olof Jisland and Ulf Käll.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026